Pancreatic cancer: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 40: Line 40:


[[Pancreatic cancer treatment by stage]] | [[Pancreatic cancer primary prevention|Primary Prevention]] | [[Pancreatic cancer secondary prevention|Secondary Prevention]] | [[Pancreatic cancer cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Pancreatic cancer future or investigational therapies|Future or Investigational Therapies]]
[[Pancreatic cancer treatment by stage]] | [[Pancreatic cancer primary prevention|Primary Prevention]] | [[Pancreatic cancer secondary prevention|Secondary Prevention]] | [[Pancreatic cancer cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Pancreatic cancer future or investigational therapies|Future or Investigational Therapies]]
==Awareness==
*November is Pancreatic Cancer Awareness ribbon|Awareness Month
*Purple is the traditional color chosen to represent pancreatic cancer awareness.
*The National Cancer Institute’s cancer research budget was $4.824 billion in 2004, an estimated $52.7 million of which was devoted to pancreatic cancer.<ref>http://pancan.org/About/pancreaticCancerStats.html</ref>
*Research spending per pancreatic cancer patient is $1145, the lowest of any leading cancer.<ref>http://pancan.org/About/pancreaticCancerStats.html</ref>
*For a list of celebrities who have succumbed to this disease, see
*The Pancreatic Cancer Action Network (PanCAN) was created as an advocacy group for pancreatic cancer.
*The national charity Pancreatic Cancer UK works to raise awareness in the UK


==References==
==References==

Revision as of 15:42, 20 January 2012

For patient information click here

Pancreatic cancer
ICD-10 C25
ICD-9 157
OMIM 260350
DiseasesDB 9510
MedlinePlus 000236
MeSH D010190

Pancreatic cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancreatic Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancreatic cancer On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancreatic cancer

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancreatic cancer

CDC on Pancreatic cancer

Pancreatic cancer in the news

Blogs on Pancreatic cancer

Directions to Hospitals Treating Pancreatic cancer

Risk calculators and risk factors for Pancreatic cancer

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Historical Perspective

Pathophysiology

Epidemiology and Demographics

Risk Factors

Screening

Causes

Differentiating Pancreatic cancer from other Disorders

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Tests | Electrocardiogram | Chest X Ray | MRI | CT | Echocardiography | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical: Medical Therapy

Surgical: Surgery

Pancreatic cancer treatment by stage | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

References


Template:WikiDoc Sources